查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1279892

2023-2030年全球慢性病管理治療和設備技術市場規模研究和預測，按疾病、按療法、按設備和區域分析

Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease by Therapy, by Device and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

全球慢性病管理治療劑和設備技術市場在2022年的價值約為203.5億美元，預計在2023-2030年的預測期間將以超過1.5%的健康成長率成長。全球慢性病管理治療和設備技術市場可定義為用於治療和管理慢性病的產品和服務市場，如糖尿病、心血管疾病、癌症、呼吸系統疾病和其他。這包括藥品、醫療設備和其他醫療技術，旨在透過管理與慢性病相關的症狀和併發症來改善病人的治療效果和生活品質。全球慢性病管理療法和設備技術市場的驅動因素是慢性病發病率的成長，老年人口的成長和醫療支出的增加。此外，對創新療法的需求增加和醫療技術的進步為2023-2030年預測期內的市場創造有利的成長機會。

全球疾病負擔研究估計，在2020年，全球有17億人至少有一種慢性病，4.15億人有多種慢性病。全球慢性病的負擔日益增加，糖尿病、心血管疾病、癌症和呼吸系統疾病等疾病影響著全世界越來越多的人。這推動對新的和有效的治療和管理策略的需求。例如，在2021年，國際糖尿病聯合會（IDF）報告指出，全球成年人的糖尿病發病率已從2019年的9.3%上升到10.5%。這意味著全世界估計有4.63億成年人患有糖尿病。同樣，根據美國癌症協會的資料，到2040年，全球癌症負擔預計將從2020年的估計1930萬新病例上升到每年2950萬新病例。這意味著在短短20年內增加了50%以上。然而，在2023-2030年的預測期內，慢性病管理療法和設備技術的高成本抑制了市場成長。

全球慢性病管理治療和設備技術市場研究涵蓋的主要地區包括亞太、北美、歐洲、拉丁美洲和中東及非洲。北美是慢性病管理治療劑和設備技術的主導市場，佔全球市場的重要佔有率。該地區強大的醫療基礎設施、高額的醫療支出和有利的報銷政策推動市場成長。在未來幾年，亞太地區是慢性病管理療法和設備技術市場中成長最快的地區。推動市場成長的因素包括人口成長、醫療支出上升和慢性病發病率上升。

該研究的目的是確定近年來不同領域和國家的市場規模，並對未來幾年的價值進行預測。本報告旨在將研究涉及的國家內的產業的定性和定量方面都涵蓋其中。

本報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，還涵蓋了微觀市場的潛在機會，供利益相關者投資，以及對競爭格局和主要參與者的疾病提供的詳細分析。

目錄

第一章：執行摘要

  • 市場簡介
  • 2020-2030年全球和細分市場的估計和預測
    • 2020-2030年，慢性病管理治療和設備技術市場，按地區分類
    • 2020-2030年，慢性病管理治療和設備技術市場，按疾病分類
    • 2020-2030年，慢性病管理治療和設備技術市場，按療法分類
    • 2020-2030年，慢性病管理治療和設備技術市場，按設備分類
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球慢性病管理治療學和設備技術市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 產業演變
    • 研究的範圍
  • 研究涵蓋的年份
  • 貨幣轉換率

第三章：全球慢性病管理治療學和設備技術市場動態

  • 慢性病管理治療藥物和設備技術市場影響分析（2020-2030）。
    • 市場驅動力
      • 慢性病的發病率不斷提高
      • 不斷成長的老年人口
      • 不斷成長的醫療開支
    • 市場挑戰
      • 慢性病管理療法和設備技術的高成本
    • 市場機會
      • 對創新療法的需求不斷增加
      • 醫療技術的進步

第四章：全球慢性病管理治療藥物和設備技術市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力影響分析
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
    • 環境
    • 法律問題
  • 最佳投資機會
  • 最佳策略
  • COVID-19影響分析
  • 顛覆性趨勢
  • 產業專家的觀點
  • 分析師建議與結論

第五章：全球慢性病管理療法和設備技術市場，按疾病分類

  • 市場簡介
  • 全球慢性病管理治療和設備技術市場，按疾病，性能-潛力分析
  • 2020-2030年全球慢性病管理治療劑和設備技術市場按疾病的估計和預測
  • 慢性病管理治療劑和設備技術市場，細項分析
    • 心血管疾病(CVD)
    • 糖尿病
    • 癌症
    • 慢性呼吸系統疾病
    • 慢性腎臟疾病
    • 神經系統疾病
    • 其他（如自身免疫性疾病、胃腸道疾病等）

第六章：全球慢性病管理治療藥物和設備技術市場，按療法分類

  • 市場簡介
  • 全球慢性病管理治療和設備技術市場，按治療方法，性能-潛力分析
  • 2020-2030年全球慢性病管理治療學和設備技術市場按療法的估計和預測
  • 慢性病管理治療學和設備技術市場，細項分析
    • 藥物治療
    • 康復治療
    • 行為治療
    • 其他（如基因治療、幹細胞治療等）

第7章：全球慢性病管理治療方法和設備技術市場，按設備分類

  • 市場簡介
  • 全球慢性病管理治療劑和設備技術市場，按設備，性能-潛力分析
  • 2020-2030年全球慢性病管理治療劑和設備技術市場按設備的估計和預測
  • 慢性病管理治療劑和設備技術市場，細項分析
    • 血糖監測設備
    • 血壓監測儀
    • 心臟監測儀
    • 呼吸系統治療設備
    • 腎臟透析機
    • 神經刺激設備
    • 其他（如胰島素泵、持續血糖監測設備等）

第八章：全球慢性病管理治療藥物和設備技術市場，區域分析

  • 最領先的國家
  • 頂級新興國家
  • 慢性病管理治療藥物和設備技術市場，區域市場簡介
  • 北美洲
    • 美國
      • 2020-2030年疾病細分的估計和預測
      • 2020-2030年，治療的細分估計和預測
      • 2020-2030年設備分類估計和預測
    • 加拿大
  • 歐洲慢性病管理治療方法和設備技術市場簡介
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區慢性病管理治療藥物和設備技術市場簡介
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 拉丁美洲慢性病管理治療藥物和設備技術市場簡介
    • 巴西
    • 墨西哥
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第九章：競爭情報

  • 主要公司SWOT分析
    • 公司1
    • 公司2
    • 公司3
  • 頂級市場戰略
  • 公司簡介
    • Medtronic plc
      • 關鍵資訊
      • 概況
      • 財務（取決於資料的可用性）
      • 產品摘要
      • 近期發展情況
    • Novo Nordisk A/S
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson Consumer Incd
    • Sanofi SA
    • Dexcom, Inc.
    • AstraZeneca plc
    • Becton, Dickinson and Company (BD)

第十章：研究過程

  • 研究過程
    • 資料探勘
    • 資料分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Chronic Disease Management Therapeutics and Device Technologies Market is valued at approximately USD 20.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% over the forecast period 2023-2030. The global chronic disease management therapeutics and device technologies market can be defined as the market for products and services that are used in the treatment and management of chronic diseases, such as diabetes, cardiovascular disease, cancer, respiratory disease, and others. This includes pharmaceuticals, medical devices, and other healthcare technologies that are designed to improve patient outcomes and quality of life by managing the symptoms and complications associated with chronic diseases. The driving factors for the Global Chronic Disease Management Therapeutics and Device Technologies Market are the growing prevalence of chronic diseases, growing geriatric population and rising healthcare expenditure. Moreover, increasing demand for innovative therapies and advances in medical technology is creating lucrative growth opportunities for the market over the forecast period 2023-2030.

The Global Burden of Disease study estimated that in 2020, 1.7 billion people worldwide had at least one chronic disease, and 415 million had multiple chronic diseases. The global burden of chronic diseases is increasing, with conditions such as diabetes, cardiovascular disease, cancer, and respiratory disease affecting a growing number of people worldwide. This is driving demand for new and effective treatments and management strategies. For instance, in 2021, the International Diabetes Federation (IDF) reported that the global prevalence of diabetes had risen to 10.5% among adults, up from 9.3% in 2019. This represents an estimated 463 million adults living with diabetes worldwide. Similarly, according to the American Cancer Society, the global cancer burden is expected to rise to 29.5 million new cases annually by 2040, up from an estimated 19.3 million new cases in 2020. This represents an increase of more than 50% in just 20 years. However, the high cost of Chronic Disease Management Therapeutics and Device Technologies stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Chronic Disease Management Therapeutics and Device Technologies Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the dominating market for chronic disease management therapeutics and device technologies, accounting for a significant share of the global market. The region's strong healthcare infrastructure, high healthcare spending, and favorable reimbursement policies are driving the market growth. The Asia Pacific region is the fastest growing region in the chronic disease management therapeutics and device technologies market in the coming years. Factors driving market growth include the growing population, rising healthcare spending, and increasing prevalence of chronic diseases.

Major market players included in this report are:

  • Medtronic plc
  • Novo Nordisk A/S
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson Consumer Inc.
  • Sanofi S.A.
  • Dexcom, Inc.
  • AstraZeneca plc
  • Becton, Dickinson and Company (BD)

Recent Developments in the Market:

  • In September 2020, Medtronic launched its MiniMed 770G insulin pump system, which uses advanced algorithms to automatically adjust insulin delivery to help people with diabetes better manage their blood sugar levels.
  • In June 2020, Abbott received FDA clearance for its FreeStyle Libre 2 continuous glucose monitoring system, which allows people with diabetes to monitor their glucose levels without the need for fingerstick.

Global Chronic Disease Management Therapeutics and Device Technologies Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Disease, Therapy, Device, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Disease offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Disease:

  • Cardiovascular diseases (CVD)
  • Diabetes
  • Cancer
  • Chronic respiratory diseases
  • Chronic kidney diseases
  • Neurological disorders
  • Others (such as autoimmune diseases, gastrointestinal disorders, and many)

By Therapy:

  • Medications
  • Rehabilitation therapy
  • Behavioral therapy
  • Others (such as gene therapy, stem cell therapy, and many)

By Device:

  • Blood glucose monitoring devices
  • Blood pressure monitors
  • Cardiac monitors
  • Respiratory therapy devices
  • Kidney dialysis machines
  • Neurostimulation devices
  • Others (such as insulin pumps, continuous glucose monitoring devices, and many)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Chronic Disease Management Therapeutics and Device Technologies Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Chronic Disease Management Therapeutics and Device Technologies Market, by Disease, 2020-2030 (USD Billion)
    • 1.2.3. Chronic Disease Management Therapeutics and Device Technologies Market, by Therapy, 2020-2030 (USD Billion)
    • 1.2.4. Chronic Disease Management Therapeutics and Device Technologies Market, by Device, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Chronic Disease Management Therapeutics and Device Technologies Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Chronic Disease Management Therapeutics and Device Technologies Market Dynamics

  • 3.1. Chronic Disease Management Therapeutics and Device Technologies Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of chronic diseases
      • 3.1.1.2. Growing Geriatric Population
      • 3.1.1.3. Rising healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Chronic Disease Management Therapeutics and Device Technologies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand for innovative therapies
      • 3.1.3.2. Advances in medical technology

Chapter 4. Global Chronic Disease Management Therapeutics and Device Technologies Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Disease

  • 5.1. Market Snapshot
  • 5.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Disease, Performance - Potential Analysis
  • 5.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Disease 2020-2030 (USD Billion)
  • 5.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 5.4.1. Cardiovascular diseases (CVD)
    • 5.4.2. Diabetes
    • 5.4.3. Cancer
    • 5.4.4. Chronic respiratory diseases
    • 5.4.5. Chronic kidney diseases
    • 5.4.6. Neurological disorders
    • 5.4.7. Others (such as autoimmune diseases, gastrointestinal disorders, and many)

Chapter 6. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Therapy 2020-2030 (USD Billion)
  • 6.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 6.4.1. Medications
    • 6.4.2. Rehabilitation therapy
    • 6.4.3. Behavioral therapy
    • 6.4.4. Others (such as gene therapy, stem cell therapy, and many)

Chapter 7. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Device

  • 7.1. Market Snapshot
  • 7.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Device, Performance - Potential Analysis
  • 7.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Device 2020-2030 (USD Billion)
  • 7.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 7.4.1. Blood glucose monitoring devices
    • 7.4.2. Blood pressure monitors
    • 7.4.3. Cardiac monitors
    • 7.4.4. Respiratory therapy devices
    • 7.4.5. Kidney dialysis machines
    • 7.4.6. Neurostimulation devices
    • 7.4.7. Others (such as insulin pumps, continuous glucose monitoring devices, and many)

Chapter 8. Global Chronic Disease Management Therapeutics and Device Technologies Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Chronic Disease Management Therapeutics and Device Technologies Market, Regional Market Snapshot
  • 8.4. North America Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.4.1. U.S. Chronic Disease Management Therapeutics and Device Technologies Market
      • 8.4.1.1. Disease breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Therapy breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Device breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.5. Europe Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.5.1. U.K. Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.2. Germany Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.3. France Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.4. Spain Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.5. Italy Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.6. Rest of Europe Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.6. Asia-Pacific Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.6.1. China Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.2. India Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.3. Japan Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.4. Australia Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.5. South Korea Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.6. Rest of Asia Pacific Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.7. Latin America Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.7.1. Brazil Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.7.2. Mexico Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.8. Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.1. Saudi Arabia Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.2. South Africa Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.3. Rest of Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Medtronic plc
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Novo Nordisk A/S
    • 9.3.3. Abbott Laboratories
    • 9.3.4. F. Hoffmann-La Roche Ltd
    • 9.3.5. GlaxoSmithKline plc
    • 9.3.6. Johnson & Johnson Consumer Incd
    • 9.3.7. Sanofi S.A.
    • 9.3.8. Dexcom, Inc.
    • 9.3.9. AstraZeneca plc
    • 9.3.10. Becton, Dickinson and Company (BD)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Chronic Disease Management Therapeutics and Device Technologies Market, report scope
  • TABLE 2. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Disease 2020-2030 (USD Billion)
  • TABLE 4. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Therapy 2020-2030 (USD Billion)
  • TABLE 5. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Device 2020-2030 (USD Billion)
  • TABLE 6. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Chronic Disease Management Therapeutics and Device Technologies Market
  • TABLE 71. List of primary sources, used in the study of global Chronic Disease Management Therapeutics and Device Technologies Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Chronic Disease Management Therapeutics and Device Technologies Market, research methodology
  • FIG 2. Global Chronic Disease Management Therapeutics and Device Technologies Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Chronic Disease Management Therapeutics and Device Technologies Market, key trends 2022
  • FIG 5. Global Chronic Disease Management Therapeutics and Device Technologies Market, growth prospects 2023-2030
  • FIG 6. Global Chronic Disease Management Therapeutics and Device Technologies Market, porters 5 force model
  • FIG 7. Global Chronic Disease Management Therapeutics and Device Technologies Market, pest analysis
  • FIG 8. Global Chronic Disease Management Therapeutics and Device Technologies Market, value chain analysis
  • FIG 9. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Chronic Disease Management Therapeutics and Device Technologies Market, regional snapshot 2020 & 2030
  • FIG 15. North America Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable